The Washington State Academy of Sciences added six people from PNNL to its 2022 class of inductees.

PNNL researchers developed a hybrid quantum-classical approach for coupled-cluster Green’s function theory that maintains accuracy while cutting computational costs.

Researchers use machine learning to speed up the analysis of aerosol datasets from mass spectrometry.

Williams will present on quantum technologies at The Economist’s Commercialising Quantum conference and the Quantum Tech Congress.

PNNL scientists have developed a new mass spectrometry method for in-depth analysis of proteins in individual cells.

Fu brings expertise in identifying defects in quantum materials to the PNNL.

Data from increasingly complex mass spectrometry instruments met with adaptable data analysis solution.

Researchers have discovered a news way to control the quantum behavior of semiconductor materials with laser light. The discovery could lead to a new kind of quantum material.

Proteomics revealed molecular mechanisms by which the drug Verapamil could prolong beta cell function in early-onset type 1 diabetes patients.

Dr. Joseph Williams explained the importance of quantum technologies in space at the University of Washington.

Focused research studies of advanced algorithms and materials are setting the stage for the next generation of quantum computers.

Quantum simulators help navigate noise on GPU-based HPC systems.

Study highlights microbiome’s role in regulating xenobiotic metabolism.

Mowei Zhou, a chemist with the Environmental Molecular Sciences Laboratory, is speaking at the ACS spring conference on his latest protein discoveries for a plant that could transform biofuels production.

Development of a one-meter path length miniature ion mobility spectrometer based on multilevel structures for lossless ion manipulations.

Governor Inslee announced the appointment of Karin Rodland to the Board of Directors of the Andy Hill Cancer Research Endowment Fund.

PNNL researchers utilized the Peeters-Devreese-Soldatov formulation to improve the accuracy of calculations for quantum chemistry.

Studying MERS-CoV may lead to better treatments for a host of respiratory illnesses, including the many variants of COVID-19.

PNNL scientists are protecting first responders and others by expanding what’s known about fentanyl, the driver of the opioid epidemic.

Researchers characterize protein signatures that indicate Acute Kidney Injury in COVID-19 patients.